DOCN vs PATH
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 24, 2026
DOCN
PATH
Investment Advisor Scores
PATH
AI Analyst Insights
Detailed Metrics Comparison
| Metric | DOCN | PATH | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 121.9512 | 15.0376 | PATH |
| PEG Ratio | 1.5379 | 0.4295 | PATH |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 22.4% | 17.3% | DOCN |
| Earnings Growth | -61.7% | 105.7% | PATH |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 55.3/100 | 41.5/100 | DOCN |
| Profit Margin | 25.0% | 19.6% | DOCN |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
DOCN
MarkdownPrice below a falling SMA50 (slope -1.1%), weak momentum, RSI 43
PATH
MarkupPrice above SMA50, rising 50-day trend (5.0% over 20 days), RSI 63
Fundamentals Snapshot
| Metric | DOCN | PATH |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 62.9 | 16.7 |
| Trailing P/E | 46.8 | 21.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.2% |
| Gross Margin | 0.6% | 0.8% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 2.57 | 0.59 |
| Dividend Yield | — | — |